Tokyo Tape
Sign in
← BrightPath Biotherapeutics

Annual report

4594.TEDINET S100TP5I
Period2023-04-01 → 2024-03-31
Filed2024-06-21
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥72,0002023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥5m2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥15m2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥3m2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥11m2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Operating income−¥1.2bn2023-04-01 → 2024-03-31StandaloneOperating income
Operating income−¥1.5bn2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income−¥1.2bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income−¥1.5bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income−¥1.5bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.7bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.8bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.2bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax−¥1.5bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income−¥1.2bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income−¥1.5bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income−¥1.5bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.7bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.9bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥1.2bnat 2024-03-31StandaloneAssets
Total assets¥1.7bnat 2023-03-31StandaloneAssets
Total assets¥2.8bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.7bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.5bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥251mat 2024-03-31StandaloneLiabilities
Total liabilities¥134mat 2023-03-31StandaloneLiabilities
Net assets / equity¥979mat 2024-03-31StandaloneNet assets
Net assets / equity¥1.6bnat 2023-03-31StandaloneNet assets
Net assets / equity¥2.5bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥3.5bnat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥3.2bnat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥1.5bnat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥3.3bnat 2021-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.0bnat 2020-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.2bn2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.5bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.8bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.8bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥8m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥2m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥18m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥36m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥107m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥691m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥432m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥569m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥2.1bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥9m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-18.212023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-24.92022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-28.552021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.142020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-44.22019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥13.52at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥24.6at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥45.4at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥69.1at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥75.49at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio77.7%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.9%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.5%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio93.7%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio91.5%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued70,741,300at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued62,891,200at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued55,253,100at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued50,817,500at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued42,101,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees24at 2024-03-31StandaloneNumber of employees
Employees32at 2023-03-31StandaloneNumber of employees
Employees38at 2022-03-31dStandaloneNumber of employees
Employees44at 2021-03-31dStandaloneNumber of employees
Employees44at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 757
ItemContextValueUnit
Interest and dividends income received ope cf inv cfPrior1YearDuration_NonConsolidatedMember21000JPY
Interest and dividends income received ope cf inv cfCurrentYearDuration_NonConsolidatedMember13000JPY
Interest expenses paid ope cf fin cfPrior1YearDuration_NonConsolidatedMember-202000JPY
Interest expenses paid ope cf fin cfCurrentYearDuration_NonConsolidatedMember－JPY
Income taxes paid ope cfPrior1YearDuration_NonConsolidatedMember-2420000JPY
Income taxes paid ope cfCurrentYearDuration_NonConsolidatedMember-1900000JPY
Net cash provided by used in operating activitiesPrior1YearDuration_NonConsolidatedMember-1204401000JPY
Net cash provided by used in operating activitiesCurrentYearDuration_NonConsolidatedMember-1156920000JPY
Purchase of property plant and equipment inv cfPrior1YearDuration_NonConsolidatedMember-1005000JPY
Purchase of property plant and equipment inv cfCurrentYearDuration_NonConsolidatedMember-6194000JPY
Purchase of intangible assets inv cfPrior1YearDuration_NonConsolidatedMember-755000JPY
Purchase of intangible assets inv cfCurrentYearDuration_NonConsolidatedMember-1454000JPY
Net cash provided by used in investment activitiesPrior1YearDuration_NonConsolidatedMember-1760000JPY
Net cash provided by used in investment activitiesCurrentYearDuration_NonConsolidatedMember-7648000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YearDuration_NonConsolidatedMember519604000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYearDuration_NonConsolidatedMember573382000JPY
Proceeds from issuance of bonds fin cfPrior1YearDuration_NonConsolidatedMember－JPY
Proceeds from issuance of bonds fin cfCurrentYearDuration_NonConsolidatedMember500000000JPY
Redemption of bonds fin cfPrior1YearDuration_NonConsolidatedMember-87500000JPY
Redemption of bonds fin cfCurrentYearDuration_NonConsolidatedMember-387500000JPY
Purchase of treasury stock fin cfPrior1YearDuration_NonConsolidatedMember-0JPY
Purchase of treasury stock fin cfCurrentYearDuration_NonConsolidatedMember－JPY
Proceeds from issuance of subscription rights to shares fin cfPrior1YearDuration_NonConsolidatedMember－JPY
Proceeds from issuance of subscription rights to shares fin cfCurrentYearDuration_NonConsolidatedMember5076000JPY
Net cash provided by used in financing activitiesPrior1YearDuration_NonConsolidatedMember432104000JPY
Net cash provided by used in financing activitiesCurrentYearDuration_NonConsolidatedMember690959000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember-774056000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember-473609000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember2305026000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1530969000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1530969000JPY
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember1057360000JPY
Accumulated depreciation ppe by groupPrior1YearInstant_NonConsolidatedMember-394977000JPY
Accumulated depreciation ppe by groupCurrentYearInstant_NonConsolidatedMember-390241000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodPrior1YearDuration_NonConsolidatedMember1168473000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodCurrentYearDuration_NonConsolidatedMember775556000JPY
Directors compensations sgaPrior1YearDuration_NonConsolidatedMember58300000JPY
Directors compensations sgaCurrentYearDuration_NonConsolidatedMember76300000JPY
Salaries and allowances sgaPrior1YearDuration_NonConsolidatedMember49829000JPY
Salaries and allowances sgaCurrentYearDuration_NonConsolidatedMember29794000JPY
Retirement benefit expenses sgaPrior1YearDuration_NonConsolidatedMember887000JPY
Retirement benefit expenses sgaCurrentYearDuration_NonConsolidatedMember545000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember10000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember48000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember1168473000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember775556000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-06-21

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass